drugset / Trial / NCT03500783

Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass

NCT03500783

RandomizedParallel-groupTriple-blindPrevention

Summary

This prospective randomized study elucidates the effects of exogenous nitric oxide delivered to the extracorporeal circulation circuit for cardioprotection against ischemia-reperfusion injury during coronary artery bypass graft surgery with cardiopulmonary bypass.

Timeline

Start
2015-05-15
Primary completion
2016-11-30
Completion
2016-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 40 ppm Other